Editing the issue of Int. J. Pharm titled Challenges in NanoMicroand Macrosystems, Int. J. Pharm. [Print ed.], 3 November 2009, vol. 381, NO. 2 Issue of the journal containing best peer reviewed fulllenght articles selected from the contributions presented at the 7th Central European Symposium on Pharmaceutical Technology and Biodelivery Systems, Ljubljana, September 2008
C.03 Guest-associated editor
Prof. Dr. Julijana Kristl, Conference Chair and Assoc. Prof. Dr. Saša Baumgartner, General Secretary prepared and lead the 4th BBBB Conference, held in Bled from 29 September to 1 October 2011.
B.01 Organiser of a scientific meeting
The present invention relates to the pharmaceutical dosage forms which enabled a controlled and/or a targeted drug delivery of an active substance tothe selected regions of gastrointestinal tract of humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2phthalimidoethoxy-acetyl)-L-alanyl-D-glutamic acid (designed as LK-423).Methods of treatment of chronic inflammatory diseases of gastrointestinal tract of humans and/or animals by using the pharmaceutical dosage forms of the invention are disclosed.
F.32 International patent
COBISS.SI-ID: 1812337The present invention provides a method of making solid micropellets of which at least 75% by weight have a diameter less than 500 μm comprising (i) melting one or more binders; and (ii) combining the one or more binders melted in step (i) with a pharmaceutically active ingredient to form solid micropellets. Solid micropellets obtainable by this method are also provided. The invention has particular utility for improving the solubility of poorly watersoluble pharmaceutically active ingredients.
F.32 International patent
COBISS.SI-ID: 3378289The objective of this study was to develop a psychometrically valid, multidimensional, self-administered, general questionnaire measuring patient satisfaction with pharmacy performance for outpatients. A multiphase development process was employed to attain this goal. In Phase I, questionnairećs content was generated using interviews with pharmacy users regarding their experiences and expectations relating to pharmacies. In Phase II, the content and format of the questionnaire was defined in a two-round modified Delphi study, where an expert panel estimated importance of generated items for patient satisfaction. In Phase III, the initial validation of the questionnaire, which included a random sample of 5,400 patients coming out of the selected pharmacies, took place. The outcome of the development process is a questionnaire that focuses on issues expressed as important by patients, takes into account services as well as the supporting structure, and includes items relevant to an individual pharmacy and demonstrates satisfactory psychometric properties.
F.22 Improvement to existing health/diagnostic methods/procedures
COBISS.SI-ID: 2806129